Putative Cognitive Enhancer VU319

NCT03220295 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Cognitive Impairment

Interventions

DRUG: Single Dose of VU319
DRUG: Single Dose Placebo
OTHER: Fed State
OTHER: Fasted State
DRUG: Dose Escalation of VU319
DRUG: Placebo Dose Escalation

Sponsor

Vanderbilt University

Collaborators

[object Object]